Céline Bellanger

494 total citations
21 papers, 318 citations indexed

About

Céline Bellanger is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Céline Bellanger has authored 21 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Pathology and Forensic Medicine and 6 papers in Oncology. Recurrent topics in Céline Bellanger's work include Lymphoma Diagnosis and Treatment (7 papers), Multiple Myeloma Research and Treatments (4 papers) and Protein Degradation and Inhibitors (4 papers). Céline Bellanger is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Multiple Myeloma Research and Treatments (4 papers) and Protein Degradation and Inhibitors (4 papers). Céline Bellanger collaborates with scholars based in France, United States and Belgium. Céline Bellanger's co-authors include Catherine Pellat‐Deceunynck, Martine Amiot, David Chiron, Benoît Tessoulin, Philippe Moreau, Cyrille Touzeau, Patricia Gomez‐Bougie, Steven Le Gouill, Sophie Maïga and Yannick Le Bris and has published in prestigious journals such as Blood, Leukemia and Cell Death and Disease.

In The Last Decade

Céline Bellanger

18 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Céline Bellanger France 9 157 120 110 88 86 21 318
Franz Josef Gassner Austria 11 140 0.9× 143 1.2× 96 0.9× 181 2.1× 178 2.1× 31 398
Dieuwertje M. Luijks Netherlands 8 135 0.9× 92 0.8× 118 1.1× 241 2.7× 145 1.7× 11 353
Tekla Hornakova Belgium 10 125 0.8× 174 1.4× 61 0.6× 141 1.6× 104 1.2× 12 369
Alexandra Moros Spain 6 230 1.5× 137 1.1× 121 1.1× 68 0.8× 33 0.4× 9 382
Elsa Maître France 10 80 0.5× 64 0.5× 146 1.3× 199 2.3× 117 1.4× 25 266
Marcus Lefebure United States 6 179 1.1× 88 0.7× 54 0.5× 56 0.6× 56 0.7× 14 288
Stefan Rebhandl Austria 7 135 0.9× 121 1.0× 60 0.5× 88 1.0× 131 1.5× 8 319
Vladimir Vorobyev Russia 10 185 1.2× 137 1.1× 45 0.4× 85 1.0× 27 0.3× 39 383
Vipul Shukla United States 12 238 1.5× 56 0.5× 50 0.5× 67 0.8× 130 1.5× 21 371
Jutta Proba Germany 6 161 1.0× 139 1.2× 32 0.3× 67 0.8× 108 1.3× 6 341

Countries citing papers authored by Céline Bellanger

Since Specialization
Citations

This map shows the geographic impact of Céline Bellanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Bellanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Bellanger more than expected).

Fields of papers citing papers by Céline Bellanger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céline Bellanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Bellanger. The network helps show where Céline Bellanger may publish in the future.

Co-authorship network of co-authors of Céline Bellanger

This figure shows the co-authorship network connecting the top 25 collaborators of Céline Bellanger. A scholar is included among the top collaborators of Céline Bellanger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céline Bellanger. Céline Bellanger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bellanger, Céline, Christelle Dousset, Yannick Le Bris, et al.. (2026). CD40/PI3K/FOXO1 axis rewiring drives microenvironment-dependent BIM silencing to sustain lymphoma growth and survival. Leukemia.
2.
Maïga, Sophie, Christelle Dousset, Agnès Moreau‐Aubry, et al.. (2025). VDAC2 primes myeloma cells for BAK-dependent apoptosis and represents a novel therapeutic target. Leukemia. 39(4). 995–1000.
3.
Bellanger, Céline, et al.. (2025). Formally proved specification of non-nested STL formulas as synchronous observers. Science of Computer Programming. 245. 103315–103315.
4.
Bellanger, Céline, Benoît Tessoulin, Christelle Dousset, et al.. (2024). Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma. Haematologica. 109(8). 2574–2584. 1 indexed citations
5.
Bellanger, Céline, Yannick Le Bris, Juliana C. Santos, et al.. (2023). CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma. Blood. 142(18). 1543–1555. 11 indexed citations
6.
Descamps, Géraldine, Céline Bellanger, Christelle Dousset, et al.. (2023). A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics. Blood. 143(13). 1242–1258. 7 indexed citations
7.
Bellanger, Céline, et al.. (2023). Towards Proved Formal Specification and Verification of STL Operators as Synchronous Observers. Electronic Proceedings in Theoretical Computer Science. 395. 188–204. 1 indexed citations
8.
Maïga, Sophie, Céline Bellanger, Catherine Pellat‐Deceunynck, et al.. (2023). BCLXL PROTAC degrader DT2216 targets secondary plasma cell leukemia addicted to BCLXL for survival. Frontiers in Oncology. 13. 1196005–1196005. 4 indexed citations
9.
Bellanger, Céline, Christelle Dousset, Yannick Le Bris, et al.. (2022). The IL32/BAFF axis supports prosurvival dialogs in the lymphoma ecosystem and is disrupted by NIK inhibition. Haematologica. 107(12). 2905–2917. 12 indexed citations
10.
Chiron, David, Emmanuelle Ménoret, Sophie Maïga, et al.. (2022). STP938, a Selective CTPS1 Inhibitor, Shows Single Agent Activity and Synergy with BCL2 Inhibition in Preclinical Models of Mantle Cell Lymphoma. Blood. 140(Supplement 1). 6014–6015. 1 indexed citations
11.
Bellanger, Céline, Yannick Le Bris, Christelle Dousset, et al.. (2022). CARD11 and BCL2A1 Join Forces to Promote Resistance to Ibrutinib/Venetoclax Combination in Lymphoma Patients. Blood. 140(Supplement 1). 2044–2045. 1 indexed citations
12.
Herviou, Laurie, Sara Ovejero, Claire Gourzonès, et al.. (2021). Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma. Clinical Epigenetics. 13(1). 174–174. 19 indexed citations
13.
Maïga, Sophie, Cyrille Touzeau, Céline Bellanger, et al.. (2020). Dual targeting of BCL2 and MCL1 rescues myeloma cells resistant to BCL2 and MCL1 inhibitors associated with the formation of BAX/BAK hetero-complexes. Cell Death and Disease. 11(5). 316–316. 34 indexed citations
14.
Gourzonès, Claire, Céline Bellanger, Sylvain Lamure, et al.. (2019). Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells. Cancers. 11(4). 439–439. 26 indexed citations
15.
Tessoulin, Benoît, Céline Bellanger, Philippe Moreau, et al.. (2019). CSF1R and BTK inhibitions as novel strategies to disrupt the dialog between mantle cell lymphoma and macrophages. Leukemia. 33(10). 2442–2453. 53 indexed citations
16.
Tessoulin, Benoît, Patricia Gomez‐Bougie, Céline Bellanger, et al.. (2019). BCL2-Family Dysregulation in B-Cell Malignancies: From Gene Expression Regulation to a Targeted Therapy Biomarker. Frontiers in Oncology. 8. 645–645. 56 indexed citations
17.
Lok, Anne, Géraldine Descamps, Benoît Tessoulin, et al.. (2018). p53 regulates CD46 expression and measles virus infection in myeloma cells. Blood Advances. 2(23). 3492–3505. 20 indexed citations
18.
19.
20.
Bellanger, Céline, et al.. (2015). Syndrome de Nager associé à une tétralogie de Fallot : une association fréquente ?. Archives de Pédiatrie. 22(9). 974–977. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franz Josef Gassner Breakdown of academic impact, for papers by Dieuwertje M. Luijks Breakdown of academic impact, for papers by Tekla Hornakova Breakdown of academic impact, for papers by Alexandra Moros Breakdown of academic impact, for papers by Elsa Maître Breakdown of academic impact, for papers by Marcus Lefebure Breakdown of academic impact, for papers by Stefan Rebhandl Breakdown of academic impact, for papers by Vladimir Vorobyev Breakdown of academic impact, for papers by Vipul Shukla Breakdown of academic impact, for papers by Jutta Proba
Rankless by CCL
2026